Tag Archives: CoViD-19

Previously researched by Oxford and AstraZeneca, a “90% effective” CoViD vaccine was only applied at a reduced dose in people under age 55. What was hoped to be ready by year’s end will now need further research. More trials will compare the reduced dose to a standard two-pair dosing of the vaccination. ‘Mr. Pangalos saidContinue reading “AstraZeneca’s vaccine reported confusing trial results”